{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:32:39Z","timestamp":1793140359622,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["EJP RD COFUND-EJP No. 825575"],"award-info":[{"award-number":["EJP RD COFUND-EJP No. 825575"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005978","name":"R\u00e9publique Fran\u00e7aise Minist\u00e8re de la Sant\u00e9 et des Sports","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-RAR4-0012"],"award-info":[{"award-number":["ANR-19-RAR4-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-PMRB-0010"],"award-info":[{"award-number":["ANR-21-PMRB-0010"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE14-0049"],"award-info":[{"award-number":["ANR-22-CE14-0049"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eclinm.2026.104114","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:35:56Z","timestamp":1786440956000},"page":"104114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["RAS\/MAPK pathway modulation with simvastatin in children with Noonan syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-5009","authenticated-orcid":false,"given":"Thomas","family":"Edouard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yline","family":"Capri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Verloes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Amouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bournez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bretones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Houang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Amsellem Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Kerdanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne","family":"Netchine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Nicolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pigeon Kherchiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-5042","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Berot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-5096","authenticated-orcid":false,"given":"Timothy","family":"Prickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Espiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gennero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Auriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-2055","authenticated-orcid":false,"given":"Benoit","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Yart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104114_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.104114_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ajmg.c.32015","article-title":"Clinical overview on RASopathies","volume":"190","author":"Zenker","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.eclinm.2026.104114_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/er.2017-00232","article-title":"The RASopathy family: consequences of germline activation of the RAS\/MAPK pathway","volume":"39","author":"Tajan","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eclinm.2026.104114_bib4","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1073\/pnas.1119803109","article-title":"Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature","volume":"109","author":"De Rocca Serra-N\u00e9d\u00e9lec","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eclinm.2026.104114_bib5","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/hmg\/ddy133","article-title":"Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth","volume":"27","author":"Tajan","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eclinm.2026.104114_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jc.2005-0983","article-title":"Noonan syndrome: relationships between genotype, growth, and growth factors","volume":"91","author":"Limal","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eclinm.2026.104114_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00431-023-05263-y","article-title":"Novel therapeutic perspectives in Noonan syndrome and RASopathies","volume":"183","author":"Saint-Laurent","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.eclinm.2026.104114_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacbts.2024.10.002","article-title":"Impact of MEK inhibition on childhood RASopathy-Associated hypertrophic cardiomyopathy","volume":"10","author":"Wolf","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.eclinm.2026.104114_bib9","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.eclinm.2026.104114_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acn3.288","article-title":"A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I","volume":"3","author":"Bearden","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.eclinm.2026.104114_bib11","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/children10091556","article-title":"Statins in children with neurofibromatosis type 1: a systematic review of randomized controlled trials","volume":"10","author":"Agouridis","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.eclinm.2026.104114_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13229-018-0190-z","article-title":"Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)","volume":"9","author":"Stivaros","year":"2018","journal-title":"Mol Autism"},{"key":"10.1016\/j.eclinm.2026.104114_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/nn.3863","article-title":"Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome","volume":"17","author":"Lee","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.eclinm.2026.104114_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102306","article-title":"Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy","volume":"24","author":"Das","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.eclinm.2026.104114_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2026.104114_bib16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3390\/ijms24021366","article-title":"Statins in children, an update","volume":"24","author":"Fiorentino","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eclinm.2026.104114_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eclinm.2026.104114_bib18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1210\/jc.2013-3060","article-title":"Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays","volume":"99","author":"Friedrich","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eclinm.2026.104114_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117487","article-title":"Reference values for cross-linked C-telopeptide of type 1 collagen and pro-collagen type1 N-terminal propeptide in children and adolescents: results from the Canadian Health Measures Survey","volume":"196","author":"Kim","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.eclinm.2026.104114_bib20","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1542\/peds.2011-0449","article-title":"Novel modeling of reference values of cardiovascular risk factors in children aged 7 to 20 years","volume":"129","author":"Mellerio","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.eclinm.2026.104114_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/pir.21.8.265","article-title":"The Child Behavior Checklist and related forms for assessing behavioral\/emotional problems and competencies","volume":"21","author":"Achenbach","year":"2000","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.eclinm.2026.104114_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000496544","article-title":"Plasma C-Type natriuretic peptide: emerging applications in disorders of skeletal growth","volume":"90","author":"Espiner","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.eclinm.2026.104114_bib23","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1210\/jc.2014-2814","article-title":"C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia","volume":"100","author":"Olney","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eclinm.2026.104114_bib24","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00787-025-02728-3","article-title":"Self-reported mental health in school-aged children using the Dominic Interactive questionnaire in the French Enabee 2022 study","volume":"34","author":"Seconda","year":"2025","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104114_bib25","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00787-025-02767-w","article-title":"Irritability in children with RASopathies, insights into emotional dysregulation and social impairment","volume":"34","author":"Serur","year":"2025","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104114_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1507\/endocrj.EJ19-0371","article-title":"Long-term efficacy and safety of two doses of Norditropin\u00ae (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients","volume":"67","author":"Horikawa","year":"2020","journal-title":"Endocr J"},{"key":"10.1016\/j.eclinm.2026.104114_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.c.32020","article-title":"Bone health in RASopathies","volume":"190","author":"Stevenson","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.eclinm.2026.104114_bib28","article-title":"Long-term effect of statins on the risk of new-onset osteoporosis: a nationwide population-based cohort study","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2026.104114_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00198-016-3844-8","article-title":"Efficacy of statins for osteoporosis: a systematic review and meta-analysis","volume":"28","author":"An","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.eclinm.2026.104114_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0140-6736(00)02400-4","article-title":"Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women","volume":"355","author":"Chan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.104114_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1507\/endocrj.EJ22-0512","article-title":"The effect of statins on bone turnover biomarkers: a systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Zhao","year":"2023","journal-title":"Endocr J"},{"key":"10.1016\/j.eclinm.2026.104114_bib32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/gme.0b013e3181d3e036","article-title":"Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials","volume":"17","author":"Yue","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.eclinm.2026.104114_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","article-title":"Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease","volume":"12","author":"Hu","year":"2024","journal-title":"Bone Res"},{"key":"10.1016\/j.eclinm.2026.104114_bib34","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","article-title":"Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo","volume":"109","author":"Yaccoby","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2026.104114_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma","volume":"24","author":"Heath","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.eclinm.2026.104114_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102224","article-title":"Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss","volume":"24","author":"Lehmann","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.eclinm.2026.104114_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S104795110800320X","article-title":"A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes","volume":"18","author":"Cerrato","year":"2008","journal-title":"Cardiol Young"},{"key":"10.1016\/j.eclinm.2026.104114_bib38","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3390\/ijms25094958","article-title":"Use of statins in heart failure with preserved ejection fraction: current evidence and perspectives","volume":"25","author":"Ovchinnikov","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eclinm.2026.104114_bib39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ajmg.a.62039","article-title":"Noonan syndrome patients beyond the obvious phenotype: a potential unfavorable metabolic profile","volume":"185","author":"Noronha","year":"2021","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.eclinm.2026.104114_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/MOP.0000000000000943","article-title":"Management of familial hypercholesterolaemia in childhood","volume":"32","author":"Ramaswami","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.eclinm.2026.104114_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacl.2022.08.009","article-title":"Guidance for the diagnosis and treatment of hypolipidemia disorders","volume":"16","author":"Bredefeld","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.eclinm.2026.104114_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/genes15081015","article-title":"Cardiac phenotype and gene mutations in RASopathies","volume":"15","author":"Faienza","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.eclinm.2026.104114_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-15-0922","article-title":"Growth patterns of patients with Noonan syndrome: correlation with age and genotype","volume":"174","author":"Cessans","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eclinm.2026.104114_bib44","first-page":"1180","article-title":"Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase","volume":"14","author":"Kato","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.eclinm.2026.104114_bib45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/cancers15030886","article-title":"Cerivastatin synergizes with trametinib and enhances its efficacy in the therapy of uveal melanoma","volume":"15","author":"Amaro","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.eclinm.2026.104114_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/pcmr.12742","article-title":"Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer","volume":"32","author":"Theodosakis","year":"2019","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:27Z","timestamp":1793136927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S2589537026003676"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104114","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS\/MAPK pathway modulation with simvastatin in children with Noonan syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104114"}}